NO20015021L - Fremgangsmåte til å nedregulere IL-5 aktivitet - Google Patents
Fremgangsmåte til å nedregulere IL-5 aktivitetInfo
- Publication number
- NO20015021L NO20015021L NO20015021A NO20015021A NO20015021L NO 20015021 L NO20015021 L NO 20015021L NO 20015021 A NO20015021 A NO 20015021A NO 20015021 A NO20015021 A NO 20015021A NO 20015021 L NO20015021 L NO 20015021L
- Authority
- NO
- Norway
- Prior art keywords
- modified
- present
- ils
- well
- analogs
- Prior art date
Links
- 102000000743 Interleukin-5 Human genes 0.000 title abstract 9
- 108010002616 Interleukin-5 Proteins 0.000 title abstract 9
- 238000000034 method Methods 0.000 title abstract 6
- 230000002222 downregulating effect Effects 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 229940100602 interleukin-5 Drugs 0.000 abstract 8
- 210000004027 cell Anatomy 0.000 abstract 3
- 150000007523 nucleic acids Chemical group 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 210000000222 eosinocyte Anatomy 0.000 abstract 1
- 230000002327 eosinophilic effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5409—IL-5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900552 | 1999-04-23 | ||
US13281199P | 1999-05-06 | 1999-05-06 | |
PCT/DK2000/000205 WO2000065058A1 (en) | 1999-04-23 | 2000-04-19 | Method for down-regulating il5 activity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20015021D0 NO20015021D0 (no) | 2001-10-15 |
NO20015021L true NO20015021L (no) | 2001-12-21 |
Family
ID=26064209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20015021A NO20015021L (no) | 1999-04-23 | 2001-10-15 | Fremgangsmåte til å nedregulere IL-5 aktivitet |
Country Status (19)
Country | Link |
---|---|
US (2) | US7285273B1 (ru) |
EP (1) | EP1173573A1 (ru) |
JP (1) | JP2002543098A (ru) |
KR (1) | KR20020084841A (ru) |
CN (1) | CN1355846A (ru) |
AU (1) | AU777952B2 (ru) |
CA (1) | CA2370391A1 (ru) |
CZ (1) | CZ20013709A3 (ru) |
EA (1) | EA200101125A1 (ru) |
EE (1) | EE200100552A (ru) |
HR (1) | HRP20010824A2 (ru) |
HU (1) | HUP0200958A3 (ru) |
IL (1) | IL145786A0 (ru) |
MX (1) | MXPA01010625A (ru) |
NO (1) | NO20015021L (ru) |
PL (1) | PL351986A1 (ru) |
SK (1) | SK14832001A3 (ru) |
TR (1) | TR200103046T2 (ru) |
WO (1) | WO2000065058A1 (ru) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9706957D0 (en) | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
GB9820525D0 (en) | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
US6913749B2 (en) | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
GB0000891D0 (en) * | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
US7097837B2 (en) | 2001-02-19 | 2006-08-29 | Pharmexa A/S | Synthetic vaccine agents |
MXPA04003901A (es) * | 2001-11-07 | 2004-07-08 | Cytos Biotechnology Ag | Disposiciones de antigenos para el tratamiento de enfermedades eosinofilicas alergicas. |
NZ532516A (en) * | 2001-11-07 | 2008-05-30 | Cytos Biotechnology Ag | Antigen arrays presenting IL-5, IL-13 or eotaxin for treatment of allergic eosinophilic diseases |
CN1615316A (zh) * | 2001-11-16 | 2005-05-11 | 法麦克萨有限公司 | 多聚体蛋白质的新免疫原性模拟物 |
CA2496409A1 (en) * | 2002-08-30 | 2004-03-11 | Glaxo Group Limited | Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
JP2006501249A (ja) * | 2002-08-30 | 2006-01-12 | グラクソ グループ リミテッド | ワクチン |
KR20060010730A (ko) * | 2003-03-24 | 2006-02-02 | 메르시아 파마, 아이엔씨. | 염증 상태를 치료하고 예방하기 위한 방법과 조성물 |
CN103091499B (zh) * | 2013-01-23 | 2015-07-08 | 三峡大学 | 一种肿瘤标志物钙网蛋白检测试剂盒的制备及应用 |
SI2958937T1 (sl) * | 2013-02-22 | 2018-12-31 | Regeneron Pharmaceuticals, Inc. | Miš, ki izraža humanizirani poglavitni histokompatibilnostni kompleks |
CN105188358B (zh) * | 2013-03-11 | 2018-01-26 | 瑞泽恩制药公司 | 表达嵌合的主要组织相容性复合物(mhc)i类分子的转基因小鼠 |
CN113307870B (zh) * | 2020-10-30 | 2022-12-23 | 上海洛启生物医药技术有限公司 | 抗il5纳米抗体及其应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5096704A (en) | 1988-11-03 | 1992-03-17 | Schering Corporation | Method of treating eosinophilia |
FR2677654B1 (fr) | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv. |
AU4377793A (en) | 1992-05-20 | 1993-12-13 | Johns Hopkins University, The | Alternative receptor therapy |
US5616488A (en) | 1992-12-07 | 1997-04-01 | Ribozyme Pharmaceuticals, Inc. | IL-5 targeted ribozymes |
DK96493D0 (da) * | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
CN1135181A (zh) | 1993-09-14 | 1996-11-06 | Cytel有限公司 | 使用泛dr结合肽改变免疫应答 |
CN1146772A (zh) | 1994-03-28 | 1997-04-02 | 美国联合生物医学公司 | 用于治疗过敏反应的合成肽免疫原 |
AUPO005496A0 (en) * | 1996-05-24 | 1996-06-13 | Bresagen Limited | An interleukin-5 antagonist |
WO1995031480A1 (en) * | 1994-05-18 | 1995-11-23 | S.P.I. Synthetic Peptides Incorporated | Heterodimer polypeptide immunogen carrier composition and method |
GB9412230D0 (en) | 1994-06-17 | 1994-08-10 | Celltech Ltd | Interleukin-5 specific recombiant antibodies |
WO1997000321A1 (en) | 1995-06-14 | 1997-01-03 | Commonwealth Scientific And Industrial Research Organisation | Immune response modulators and uses therefor |
AU729579B2 (en) * | 1996-10-23 | 2001-02-01 | Trustees Of The University Of Pennsylvania, The | Immunotherapy and improved vaccines |
AUPO390396A0 (en) | 1996-11-29 | 1996-12-19 | Csl Limited | Novel promiscuous T helper cell epitopes |
JP2001509178A (ja) | 1997-01-22 | 2001-07-10 | ザイコス インク. | 核酸を輸送するための微粒子 |
AU7132098A (en) * | 1997-04-18 | 1998-11-13 | Tanox Biosystems, Inc. | Il-5r antagonists for treatment of inflammation, asthma and other allergic diseases |
NZ511055A (en) * | 1998-10-05 | 2003-10-31 | Pharmexa As | Novel methods for therapeutic vaccination |
-
2000
- 2000-04-19 EP EP00920423A patent/EP1173573A1/en not_active Ceased
- 2000-04-19 US US09/980,916 patent/US7285273B1/en not_active Expired - Fee Related
- 2000-04-19 PL PL00351986A patent/PL351986A1/xx not_active Application Discontinuation
- 2000-04-19 IL IL14578600A patent/IL145786A0/xx unknown
- 2000-04-19 JP JP2000614393A patent/JP2002543098A/ja active Pending
- 2000-04-19 EE EEP200100552A patent/EE200100552A/xx unknown
- 2000-04-19 SK SK1483-2001A patent/SK14832001A3/sk unknown
- 2000-04-19 CN CN00806367A patent/CN1355846A/zh active Pending
- 2000-04-19 CZ CZ20013709A patent/CZ20013709A3/cs unknown
- 2000-04-19 WO PCT/DK2000/000205 patent/WO2000065058A1/en not_active Application Discontinuation
- 2000-04-19 AU AU41008/00A patent/AU777952B2/en not_active Ceased
- 2000-04-19 CA CA002370391A patent/CA2370391A1/en not_active Abandoned
- 2000-04-19 KR KR1020017013585A patent/KR20020084841A/ko not_active Application Discontinuation
- 2000-04-19 EA EA200101125A patent/EA200101125A1/ru unknown
- 2000-04-19 TR TR2001/03046T patent/TR200103046T2/xx unknown
- 2000-04-19 MX MXPA01010625A patent/MXPA01010625A/es unknown
- 2000-04-19 HU HU0200958A patent/HUP0200958A3/hu unknown
- 2000-04-21 US US09/556,818 patent/US6746669B1/en not_active Expired - Fee Related
-
2001
- 2001-10-15 NO NO20015021A patent/NO20015021L/no not_active Application Discontinuation
- 2001-11-08 HR HR20010824A patent/HRP20010824A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU777952B2 (en) | 2004-11-04 |
AU4100800A (en) | 2000-11-10 |
HUP0200958A3 (en) | 2004-11-29 |
TR200103046T2 (tr) | 2002-06-21 |
HUP0200958A2 (en) | 2002-06-29 |
SK14832001A3 (sk) | 2003-02-04 |
HRP20010824A2 (en) | 2002-12-31 |
MXPA01010625A (es) | 2003-09-04 |
IL145786A0 (en) | 2002-07-25 |
NO20015021D0 (no) | 2001-10-15 |
CA2370391A1 (en) | 2000-11-02 |
EA200101125A1 (ru) | 2002-04-25 |
WO2000065058A1 (en) | 2000-11-02 |
CN1355846A (zh) | 2002-06-26 |
CZ20013709A3 (cs) | 2002-11-13 |
US7285273B1 (en) | 2007-10-23 |
US6746669B1 (en) | 2004-06-08 |
PL351986A1 (en) | 2003-07-14 |
KR20020084841A (ko) | 2002-11-11 |
EP1173573A1 (en) | 2002-01-23 |
JP2002543098A (ja) | 2002-12-17 |
EE200100552A (et) | 2002-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20015021L (no) | Fremgangsmåte til å nedregulere IL-5 aktivitet | |
Koppelman et al. | Purification and immunoglobulin E‐binding properties of peanut allergen Ara h 6: evidence for cross‐reactivity with Ara h 2 | |
Kettner et al. | Api m 6: a new bee venom allergen | |
DE69924392D1 (de) | Verfahren zur hemmung der aktivität von osteoprotegerin-liganden | |
Gavrovic-Jankulovic et al. | A novel recombinantly produced banana lectin isoform is a valuable tool for glycoproteomics and a potent modulator of the proliferation response in CD3+, CD4+, and CD8+ populations of human PBMCs | |
WO1998014596A3 (en) | Disease associated protein tyrosine phosphatases | |
Petersen et al. | Group 13 grass allergens: structural variability between different grass species and analysis of proteolytic stability | |
Grobe et al. | Properties of group I allergens from grass pollen and their relation to cathepsin B, a member of the C1 family of cysteine proteinases | |
Hoffman | Allergens in Hymenoptera venom XVI: Studies of the structures and cross-reactivities of vespid venom phospholipases | |
EP1219301B1 (en) | Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins | |
Welle et al. | Properties and solubilization of the prenyltransferase of isoflavonoid phytoalexin biosynthesis in soybean | |
WO1998018822A3 (en) | Novel human lim proteins | |
Wopfner et al. | The alpha and beta subchain of Amb a 1, the major ragweed-pollen allergen show divergent reactivity at the IgE and T-cell level | |
WO1998025956A3 (en) | Human GTP-binding proteins | |
Kohama et al. | Ca2+-binding light chain of Physarum myosin confers inhibitory Ca2+-sensitivity on Actin-myosin-ATP interaction via actin | |
Nakayama et al. | Affinity purification of nicotinic acetylcholine receptor from rat brain | |
AU776154B2 (en) | Method for isolating and purifying grass pollen allergens | |
EP3430390A1 (en) | Molecular origin of allergy | |
Hülsmann et al. | Cardiac lipoprotein lipase: effects of lipopolysaccharide and tumor necrosis factor | |
Etzler | Isolation and characterization of subunits of DB58, a lectin from the stems and leaves of Dolichos biflorus | |
Dhyani et al. | A clinically relevant major cross‐reactive allergen from mesquite tree pollen | |
WO2012105541A1 (ja) | 新規ヒノキ花粉アレルゲン | |
Müller et al. | Ubiquitin and ubiquitination in cells from the marine sponge Geodia cydonium | |
WO1998018942A3 (en) | Novel human rab proteins | |
WO1998036068A3 (en) | Human p24 vesicle proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |